Incyte Corporation has announced that Bill Meury has been appointed as the new President and CEO, effective immediately. Meury, a seasoned industry leader with a background at Karuna, Anthos, and Allergan, succeeds Hervé Hoppenot, who is retiring after 11 years at the helm. Additionally, Julian Baker has been elected as the Chairman of the Board of Directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.